BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28370518)

  • 21. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor].
    García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M
    Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
    Roos C; Vis JY; Scheepers HC; Bloemenkamp KW; Duvekot HJ; van Eyck J; de Groot C; Kok JH; Opmeer BC; Oudijk MA; Papatsonis DN; Porath MM; Sollie K; Spaanderman ME; Lotgering FK; van der Post JA; Mol BW
    J Matern Fetal Neonatal Med; 2016; 29(10):1556-61. PubMed ID: 26103778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Wallwiener D; Schmidt S
    J Perinat Med; 2005; 33(5):383-91. PubMed ID: 16238532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage.
    Benson JE; Landy HJ; Ghidini A; Drassinower D; Poggi SH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2330-2. PubMed ID: 22694302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescribing patterns of antenatal corticosteroids in women with threatened preterm labor.
    Wilms FF; van Baaren GJ; Vis JY; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Bolte AC; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; Vandenbussche FP; Woiski MD; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():47-53. PubMed ID: 26149479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of foetal fibronectin testing: Admissions, maternal interventions and costs at 1 year.
    Parisaei M; Currie J; O'Gorman N; Morris S; David AL
    J Obstet Gynaecol; 2016 Oct; 36(7):888-892. PubMed ID: 27147420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Predictive value of combined fibronectin and ultrasound cervical assessment in twin pregnancies].
    Deplagne C; Maurice-Tison S; Coatleven F; Vandenbossche F; Horovitz J
    Gynecol Obstet Fertil; 2013 May; 41(5):289-96. PubMed ID: 22521981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
    Nikolova T; Bayev O; Nikolova N; Di Renzo GC
    J Perinat Med; 2015 Jul; 43(4):395-402. PubMed ID: 25562603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).
    Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HC; Bloemenkamp KW; Bolte AC; Cornette J; Derks JB; Duvekot JJ; van Eyck J; Kwee A; Opmeer BC; van Pampus MG; Lotgering FK; Scherjon SA; Sollie KM; Spaanderman ME; Willekes C; van der Post JA; Mol BW
    BMC Pregnancy Childbirth; 2009 Sep; 9():38. PubMed ID: 19723320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between maternal biomarkers and pathways to preterm birth in twin pregnancies.
    Bergh E; Rebarber A; Oppal S; Saltzman DH; Klauser CK; Gupta S; Fox NS
    J Matern Fetal Neonatal Med; 2015 Mar; 28(5):504-8. PubMed ID: 24849127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of preterm labor: the role of fetal fibronectin in parents with symptoms].
    Karamisheva V; Ivanov S; Nikolov A; Jordanova D; Dimitrov G; Nachev A
    Akush Ginekol (Sofiia); 2014; 53 Suppl 1():15-9. PubMed ID: 25510036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Identification of preterm labor: the role of the fibronectin and ultrasound cervicometry and their association].
    Di Renzo GC; Giardina I; Coata G; Di Tommaso M; Facchinetti F; Petraglia F; Tranquilli AL; Rizzo N
    Minerva Ginecol; 2011 Dec; 63(6):477-83. PubMed ID: 22036751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length.
    Fox NS; Saltzman DH; Klauser CK; Peress D; Gutierrez CV; Rebarber A
    Am J Obstet Gynecol; 2009 Sep; 201(3):313.e1-5. PubMed ID: 19733285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of bedside fetal fibronectin testing varies according to treatment algorithm.
    Sullivan A; Hueppchen NA; Satin AJ
    J Matern Fetal Med; 2001 Dec; 10(6):380-4. PubMed ID: 11798447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of combined cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high-risk women.
    Bolt LA; Chandiramani M; De Greeff A; Seed PT; Kurtzman J; Shennan AH
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):928-32. PubMed ID: 21190414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effective standardization of preterm labor evaluation.
    Rose CH; McWeeney DT; Brost BC; Davies NP; Watson WJ
    Am J Obstet Gynecol; 2010 Sep; 203(3):250.e1-5. PubMed ID: 20816147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.